Evolution of pathogens with cross-immunity in response to healthcare interventions.

Cross-immunity, as an evolutionary driver, can contribute to pathogen evolution, particularly pathogen diversity. Healthcare interventions aimed at reducing disease severity or transmission are commonly used to control diseases and can also induce pathogen evolution. Understanding pathogen evolution in the context of cross-immunity and healthcare interventions is crucial for infection control.

Modelling and optimising healthcare interventions in a model with explicit within- and between-host dynamics.

Given an endemic infectious disease and a budget, how do we optimally allocate interventions to control the disease? This paper shows that the optimal strategy varies depending on the budget, the type of intervention, the trajectory of pathogen load, and the objective. Using a model with explicit within- and between-host dynamics, we model isolation, supportive treatment, and specific treatment. Isolation and supportive treatment affect the transmission coefficient and the disease-induced mortality rate, respectively, in the between-host dynamics.

Virulence management: Closing the feedback loop between healthcare interventions and virulence evolution.

We study the evolution of virulence of an endemic pathogen in response to healthcare interventions which affect host recovery and pathogen transmission. By anticipating the evolutionary response of the pathogen we may develop effective long-term management strategies for controlling the impact of the endemic on the society. To that end, we use standard Adaptive Dynamics techniques in an SIS model.

Apoptosis in virus infection dynamics models.

In this paper, on the basis of the simplified two-dimensional virus infection dynamics model, we propose two extended models that aim at incorporating the influence of activation-induced apoptosis which directly affects the population of uninfected cells. The theoretical analysis shows that increasing apoptosis plays a positive role in control of virus infection. However, after being included the third population of cytotoxic T lymphocytes immune response in HIV-infected patients, it shows that depending on intensity of the apoptosis of healthy cells, the apoptosis can either promote or comfort the long-term evolution of HIV infection.